COVID-19 susceptibility in long-term care facilities
- PMID: 34104900
- PMCID: PMC8175054
- DOI: 10.1016/S2666-7568(21)00119-7
COVID-19 susceptibility in long-term care facilities
Conflict of interest statement
MKA reports grants from the Canadian Frailty Network, Canadian Institutes of Health Research, Public Health Agency of Canada, Sanofi, Pfizer, and GlaxoSmithKline, and personal fees from Pfizer, Sanofi, and Seqirus, outside the submitted work. LB reports grants from CIHR, the Canadian COVID Immunity Task Force, Gilead, ViiV, Abbvie, Merck, and honoraria for advisory activities from Gilead, ViiV, Abbvie, and Merck outside the submitted work.
Comment on
-
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study.Lancet Healthy Longev. 2021 Jun;2(6):e362-e370. doi: 10.1016/S2666-7568(21)00093-3. Epub 2021 Jun 3. Lancet Healthy Longev. 2021. PMID: 34104901 Free PMC article.
References
-
- Andrew M, Searle SD, McElhaney JE. COVID-19, frailty and long-term care: Implications for policy and practice. J Infect Dev Ctries. 2020;14:428–432. - PubMed
-
- International Long-Term Care Policy Network https://ltccovid.org/international-reports-on-covid-19-and-long-term-care/
-
- Sarabia-Cobo C, Pérez V, de Lorena P. Experiences of geriatric nurses in nursing home settings across four countries in the face of the COVID-19 pandemic. J Adv Nurs. 2021;77:869–878. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
